전기‧정보세미나3(4과세미나) 개최 안내
* 연사: 서울대학교 의과대학 방영주 교수
아래와 같이 전기‧정보세미나3(4과세미나)를 개최합니다.
관심있는 분들의 많은 참여 부탁드립니다.
Precision medicine (PM) is an approach to disease treatment and prevention that seeks to maximize effectiveness by taking into account individual variability in genes, environment, and lifestyle. Cancer arises as a result of accumulation of genetic changes in a cell, and a number of therapeutics targeting protein products of ‘driver oncogenes’ have been developed. This has led to realization of ‘precision medicine’ in treating patients with cancers, first. This approach is being explored in prognostication and early detection of cancer, and finally, will be employed in the prevention of cancer. And, this approach is being applied to other diseases.
Yung-Jue Bang MD, PhD
Dr. Bang, a medical oncologist, had worked for Seoul National University College of Medicine and Hospital from 1986 to Feb., 2020. He served many positions including Director of Cancer Research Institute, Chairman of Department of Internal Medicine, and the President of Biomedical Research Institute and Director of Clinical Trials Center of Seoul National University Hospital, and Chairman of the Korean Cancer Association.
Dr. Bang has co-authored more than 500 papers in SCI-indexed journals including New England Journal of Medicine and Lancet (H-index 88). He was primarily interested in Phase I trials and gastric cancer trials, and was the Coordinating Investigator of a number of international clinical trials including ToGA study, CLASSIC study, SHINE study, GOLD study, JAVELIN Gastric 300 study, and KEYNOTE 585 study.Currently, Dr. Bang is Emeritus Professor of Seoul National University and the CEO of Bang & Ock Consulting for new drug development.